𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Motor changes during sertraline treatment in depressed patients with Parkinson’s disease

✍ Scribed by J. Kulisevsky; J. Pagonabarraga; B. Pascual-Sedano; A. Gironell; C. García-Sánchez; M. Martínez-Corral


Book ID
111065570
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
95 KB
Volume
15
Category
Article
ISSN
1351-5101

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Sertraline for the treatment of depressi
✍ Dr. Robert A. Hauser; Theresa A. Zesiewicz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

## Abstract Although antidepressant medications are commonly used to treat depression in Parkinson's disease (PD), little information is available regarding their safety and efficacy in this condition. Sertraline is a relatively selective serotonin reuptake inhibitor with some dopamine reuptake inh

Bereitschaftspotential in depressed and
✍ Saša R. Filipović; Nadežda Šternić; Marina Svetel; Nataša Dragašević; Dušica Leč 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract Impaired initiation and slowed execution of movements are two of the principal characteristics of Parkinson's disease (PD). A similar pattern of movement impairments (psychomotor retardation) can be seen frequently in patients with idiopathic depression. In addition, affective disorders

Depression in patients with Parkinson's
✍ Jeffrey L. Cummings; Donna L. Masterman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Parkinson's disease (PD) is a disabling neurodegenerative condition commonly complicated by the existence of comorbid depression. The prevalence rates of depression in this patient group have been reported to be as high as 40%. Currently, depression in PD is undertreated; there have been few control